ABSTRACT. The increased morbidity during pregnancies complicated by hematologic or liver disease has generally been attributed to the metabolic abnormalities of the illness itself. Because tetrapyrrole concentrations are elevated in these conditions, we introduced bilirubin or heme (prepared as 10 mM solutions) into the air sac of fertilized chicken eggs to study their effect on the growth of normal chicken embryos. In 9-d eggs, the injection of 0.06 mL heme resulted in significant embryo growth inhibition as indicated by overall wt (91 2 3% versus control), tibia length (84 f 2%), tibia wt (81 + 3%), femur length (88 + I%), and femur wt (78 + 3%); doses greater than 0.10 mL resulted in substantial fetal losses. The injection of 0.06 mL bilirubin into the same-age eggs also resulted in less than normal tibia length (87 2 2% versus control), tibia wt (75 2 4%), femur length (91 + 2%), and femur wt (81 2 3%); larger doses resulted in more pronounced growth inhibition, but fetal losses were less common than with heme. Older chick embryos (12-d) appeared more resistant to the effects of bilirubin: 0.15 mL bilirubin inhibited only tibia and femur wt; larger doses were required to significantly suppress the other growth parameters. The sameage chicken embryos, however, remained exquisitely sensitive to heme; 0.05 mL resulted in less than normal whole embryo wt (88 + 2% versus control), tibia length (80 2 I%), tibia wt (76 +. I%), femur length (78 + I%), and femur wt (77 + 1%). Substantial fetal loss occurred with heme doses above 0.10 mL as well as among the less mature chicks. Significant inhibition of the growth of long bones (tibia and femur) also occurred when we added 0.05 mM bilirubin or 0.025 mM Hb to bones maintained in organ culture in vitro for 5 d. We conclude that several heme compounds and bilirubin inhibit the growth and survival of normal chick embryos in ovo and in vitro.We suggest that prenatal exposure to high levels of these compounds may have a previously underestimated negative influence on fetal development (Pediatr Res 27: 617-621, 1990) In pregnancies complicated by maternal hematologic or liver diseases, the risk of adverse fetal outcome is higher than normal. How these maternal illnesses harm the fetus remains poorly understood (1-3). Although maternal hematologic or liver diseases are systemic disorders with multiple metabolic abnormalities that could affect fetal outcome, one feature they share is sustained elevation of circulating tetrapyrroles (heme compounds and/or bilirubin), which may affect fetal metabolism directly. Supported by NIH Grant AR 37326.
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In pregnancies complicated by maternal hematologic or liver diseases, the risk of adverse fetal outcome is higher than normal. How these maternal illnesses harm the fetus remains poorly understood (1-3). Although maternal hematologic or liver diseases are systemic disorders with multiple metabolic abnormalities that could affect fetal outcome, one feature they share is sustained elevation of circulating tetrapyrroles (heme compounds and/or bilirubin), which may affect fetal metabolism directly.
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That exposure to heme compounds or bilirubin may exert a direct negative influence on fetal growth and development has not received attention, but our recent studies prompt us to examine this possibility carefully. We have demonstrated that several tetrapyrroles can profoundly inhibit the growth of embryonic chicken cartilage in organ culture in vitro (4-7), the growth of normal, growing rats in vivo (8) , and the proliferation of chondrocytes in cell culture (9). Whereas the potential range of tetrapyrrole-induced inhibition in tissues other than cartilage has not yet been specifically demonstrated, a broader antianabolic effect is suggested by the observed dose-dependent growth retardation of intact rats overloaded with heme in vivo (8).
We designed this study to assess whether bilirubin and heme can influence the growth and development of normal, growing chick embryos in ovo and to define the potential of this experimental model for further studies of tetrapyrrole action.
MATERIALS AND METHODS

Materials.
Waymouth's tissue culture medium was from GIBCO Laboratories (Grand Island, NY), FCS was from Hazleton Biologicals (Lenexa, KS). Bovine hemin (heme), crystalline bilirubin, Hb, and all other chemicals were from Sigma Chemical (St. Louis, MO). Fertilized chicken eggs were from Richglo (El Campo, TX).
Unconjugated bilirubin was dissolved at pH 10 with 2 N NaOH; albumin was then stirred in, and pH adjusted back to 7.7 to 'prepare a 10 mM stock solution containing 1 mg/mL albumin (7). Fresh solutions were made twice a wk and stored in opaque containers at 4°C; our previous studies demonstrated that the addition of excess albumin does not modify the bioactivity of bilirubin (7). Heme (or Hb) powder was brought into solution at pH 1 i with 2 N NaOH, pH was titrated back to 7.7, and a 10 mM stock solution was prepared, which was also stored at 4°C (6). All treatment solutions were filtered through 0.022 nm Millipore filters (Millipore, Bedford, MA) before injection. Heme concentrations were confirmed spectrophotometrically and bilirubin concentrations by the clinical chemistry laboratory in representative samples.
Administration of hemelbilirubin in ovo.
The injection methods were modified from previous studies (10-1 5). Fertilized eggs were maintained at 37°C during the experimental period. Before injection, the blunt end was cleaned with alcohol and allowed to dry. The eggshell was then punctured through the air sac with a 23-gauge needle attached to a I-mL syringe, and the appropriate treatment solution was introduced into the air sac. The puncture hole was sealed with wax and the egg returned to the incubator. In preliminary experiments, we evaluated the effect of injecting 0.05-0.60 mL buffer and found that the measured growth parameters were no different from those for uninjected eggs. Thus, the lower end of this volume range was chosen; in all experiments, a buffer solution was injected into the eggs designated as controls.
At the end of the incubation period, the shells were cracked, and the embryos inspected for a spontaneous heartbeat; only live 6 18 VASSILOPOULOU '-SELLIN ET AL. embryos were used for the accumulation of growth parameter data. The embryos were cleansed of other egg contents and weighed; they were then dissected, and tissues were removed for measurement. The pelvis and the hind legs were separated and cleansed of adjacent soft tissues; the tibia and femur lengths were measured with calipers, and the pelvic rudiment, tibia, and femur were weighed both wet and after stepwise dehydration in ethanol and ether. The correlation between wet and dry wt was excellent (dry:wet ratio, 23 + 0.4% for 345 bones), and the data are generally given as wet wt.
In the time-course experiments, 9-d eggs were injected with 0.1 mL heme or buffer, and growth parameters compared after 2, 4, or 7 d. The impact of a single dose of heme was most apparent between 2 and 4 d. In dose-response studies, therefore, a 3-d interval was chosen.
The doses of heme or bilirubin were only semiquantitative. Based on the average egg wt of 50-55 g, the volume was approximately 50 mL; we used a range from 0.05 mL (i.e. 0.3 mg/egg or approximately 0.01 mM) to 0.60 mL (i.e. 3 .6 mg/egg or approximately 0.6 mM), concentrating on a 0.05-0.15 mL injected volume in most experiments. Our previous in vitro studies demonstrated significant growth inhibition with 0.05-0.10 mM heme or bilirubin (6, 7); furthermore, these concentrations are consistent with the circulating levels of bilirubin (or heme) likely to prevail in clinical conditions (from 0.05 mM or 3 mg/dL to 0.15 mM or 9 mg/dL).
Prolonged organ cultures. Prolonged organ cultures were modified from previous studies (4-7). Briefly, pelvic rudiments, tibiae, and femurs were removed from ll- 
RESULTS
Heme or bilirubin introduction into fertilized chicken eggs.
At the end of the incubation period, the chorio-allantoic membranes were still stained with the black pigment of heme or the yellowishgreen pigment of bilirubin. The livers of the treated chicks were darker than controls, but there was no significant difference in their wt. Although we encountered two deformed chicks in bilirubin-treated eggs, we consider this a probable coincidence because of the chick age at injection. In the older chicks (injected at 12 d), the pelvic rudiment normally has evidence of calcification and becomes invaded with blood vessels; both of these developmental changes were absent in the treated chicks. In addition, the treated chicks had poorly developed beaks and nails, a relatively immature eye configuration, and scantier feather cover.
Finally, the larger doses of bilirubin and especially heme were very toxic and resulted in substantial fetal losses (Table I) . Although the injection of buffer and of low-dose heme or bilirubin were well tolerated, resulting in minimal (5-7%) fetal loss (equivalent to the incidence in untreated eggs), fetal losses were greater than 40% at higher doses. Thus, in ovo exposure to bilirubin or heme can be lethal to the growing chick embryo.
Time course study of effect of one injection of heme in ovo. In 9-d eggs, significant growth retardation was evident 2 d after the administration of 0.10 mL heme (Table 2 ). This was reflected in below normal overall embryo wt, tibia and femur wt and length, and pelvic rudiment wt. Some growth delay persisted after 4 d but apparent catch-up growth restored the size of the treated chicks by 7 d. Thus, the growth inhibition induced by a modest g) were injected with increasing concentrations of heme or bilirubin, and growth parameters were measured after 3 d (Table 3) . Because of substantial fetal losses with higher doses, only the effect of the lower concentrations was analyzed. A significant decrease in several growth parameters was found in all treated groups. The impact on long bone growth (both length and wt) was the most consistent; tibia or femur size was 10-25% less than normal at all concentrations of heme and bilirubin. Overall embryo and pelvic rudiment sizes were, generally, smaller at the higher doses. The tissues of the treated chicks were more friable than controls but morphologically normal. Thus, the exposure of immature chick embryos to modest doses of heme or bilirubin results in significant growth retardation in ovo.
Dose-response study of effects of heme and bilirubin on growth of 12-d chick embryos.
A separate group of more mature, 12-d, chick embryos (starting wt 7.32 f 0.17 g) was injected with increasing doses of heme or bilirubin, and growth parameters were measured after 3 d (Table 4) . To assess potential age-related changes in sensitivity to ambient tetrapyrroles, we adjusted the injected doses for chick size. (Thus, 0.15 mL for this group is approximately equivalent to 0.06 mL for the 9-d group, and 0.30 mL is equivalent to 0.13 mL.) These more mature chicks appear to be relatively resistant to the inhibitory effects of bilirubin, since the 0.15 mL dose caused only partial and modest decrease in tibia and femur wt; more pronounced inhibition was found with the higher 0.30 mL dose. Fetal losses were also less common. The administration of heme, however, resulted in profound growth inhibition even at low concentrations; embryos, tibiae, and femurs were significantly smaller than normal after 0.05 mL heme injections with striking inhibition of all growth parameters and a substantial fetal loss rate at the larger 0.30 mL dose. The heme-induced inhibition in this group appeared more severe than the effect of equivalent doses in the 9-d chicks.
Effects of bilirubin and Hb on growth of embryonic chick skeletal tissues in vitro. We also assessed the effect of bilirubin or Hb on the growth of long bones directly by adding these compounds to tibiae and femurs maintained in organ culture for 5 d (Table 5) . In these experiments, we substituted Hb for heme, as this related heme compound can also become elevated in hematologic diseases. Our previous studies demonstrated that Hb inhibits embryonic chick pelvic rudiment growth and that the inhibition is attributable to the heme portion of the Hb molecule (5). Pelvic rudiment measurements were included for comparison with our previous studies; the observed inhibition was consistent with those results (4-7). Both 0.05 mM bilirubin and 0.25 mM Hb produced modest but significant 8-12% de- t Growth parameters expressed as direct measurement.
$ Growth parameters expressed as percentages of the appropriate controls within each assay. 9 p < 0.05 vs control.
creases in tibia and femur length after 2 and 5 d as well as in bone wt at the conclusion of the organ culture period. Thus, these compounds modify the growth potential of skeletal tissues both systemically in ovo and directly in vitro.
DISCUSSION
Our study demonstrates that exposure of normal, growing chicken embryos to modest concentrations of bilirubin or heme causes severe growth retardation and increased fetal loss. Thus, ambient tetrapyrroles may have a previously underestimated impact on growth and development.
Several hereditary hematologic (16) and liver (1 7-20) diseases are associated with growth failure and specific skeletal anoma1ies.These complications are generally attributed to nonspecific factors relating to systemic metabolic derangements but are poorly understood. In addition, maternal hematologic or liver dysfunction during pregnancy is associated with increased fetal deaths (1-3); this is attributed to the maternal metabolic dysregulation, but the pathophysiology remains ill-defined. Our findings support the concept that abnormally circulating heme compounds and their metabolites, which prevail in hematologic and liver disease, can be directly responsible for at least some of the fetal abnormalities.
How tetrapyrroles inhibit growth is not clear, but our in vitro studies of cartilage growth models demonstrate that these compounds interfere with overall tissue growth as well as radiolabeled isotope incorporation into RNA/protein/proteoglycans (4-9). Ample evidence suggests other metabolic activities of tetrapyrrole compounds. Heme can inhibit the growth of erythropoetic (2 1, 22) and ovarian cell lines (23) and is a naturally occurring ligand for peripheral benzodiazepine receptors (24, 25). Bilirubin can abolish respiratory control, uncouple oxidative phosphorylation, and induce mitochondrial swelling in liver, heart, brain tissues (26) , and cultured cells (27); it has also been shown to lower mitochondrial ATP and electrolyte content in renal slices (28) and to inhibit superoxide production by polymorphonuclear cells (29). Hematoporphyrins are potent cytocidal agents in tumor phototherapy (30, 3 1) but can also inhibit cartilage metabolism (32) and cell proliferation (33, 34) in the absence of light. Finally, bile pigments are vital to lower organisms, being responsible for the spectrum of photosynthetic energy transfer reactions (17) . Thus, these compounds possess the intrinsic ability to interact with a wide variety of tissues, in which they exert a broad range of antianabolic effects. wefound a reproducible, although modest, inhibition of embryonic growth after the introduction of small doses of either bilirubin or heme in ovo; the tetrapyrroles interfered with both long and flat bone growth both in ovo and in vitro. The findings are consistent with our earlier studies (4-9), except for the toxic and irreversible component of tissue action, which was not readily apparent in vitro. In addition, these compounds appear to influence the development of a variety of fetal tissues, suggesting that they may possess a wider range of antianabolic bioactivity than appreciated earlier.
